Echevarria Joseph 4
4 · PFIZER INC · Filed Mar 30, 2026
Research Summary
AI-generated summary of this filing
Pfizer Director Joseph Echevarria Receives Award
What Happened
Joseph Echevarria, a director of Pfizer Inc. (PFE), was granted 1,710.429 derivative units on 2026-03-27 under a director compensation program. The units were valued at $27.04 each for a total value of $46,250. This transaction is coded as an award/grant (A) of phantom-share units — not an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-27; Filing date (Form 4): 2026-03-30 (timely filing).
- Instrument: 1,710.429 phantom-share units @ $27.04 each — total $46,250. (Transaction code A = Award/Grant)
- Shares/units owned after transaction: Not specified in this filing.
- Footnotes: F1 — each unit equals one phantom share of common stock. F2 — units represent deferred director compensation (including dividend equivalents) that will be settled in cash or common stock at the director’s election following retirement from the Board.
- No indication of a 10b5-1 plan, tax-withholding sale, or other special disposition in this filing.
Context
This was a routine director compensation award of deferred, phantom-share units rather than a market buy or sale. Such grants are common for board compensation and are settled later (cash or stock) when the director retires, so they do not necessarily reflect an immediate trading signal about company prospects.
Insider Transaction Report
- Award
Phantom Stock Units
[F1][F2]2026-03-27$27.04/sh+1,710.429$46,250→ 153,398.145 total→ Common Stock (1,710.429 underlying)
Footnotes (2)
- [F1]Each unit represents one phantom share of common stock.
- [F2]These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.